Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567294 · ClinicalTrials.gov registry record · Phase 3
Evaluating Ways to Improve Medication Use Among People With Osteoporosis
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,087
- Enrollment target
NCT00567294: Completed Phase 3 study, sponsored by Brigham and Women's Hospital.
NCT00567294 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,087 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (170% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567294, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,087 participants
- Enrollment target
Study Summary
Osteoporosis is a common bone disease in older adults in which the bones become weaker and prone to fracture. Medications are available to slow or even stop disease progression. However, very few adults who are prescribed osteoporosis medications actually follow through with filling their prescriptions and taking the medications. Ways to improve medication use have not been well developed or adequately tested. The purpose of this study is to evaluate a telephone coaching program, with or without helpful adherence notifications to doctors, in improving treatment adherence in older adults who are starting an osteoporosis medication.
Interventions
- BEHAVIORAL Mailed education
- BEHAVIORAL Telephone coaching program for patients
- BEHAVIORAL Medication adherence alert program for doctors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,087 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
What the finished NCT00567294 record still lists
NCT00567294 is an interventional study that assigns participants to a tested intervention. Its 2,087 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (170% higher).
The record links to 0 conditions, and to 3 interventions - of which Mailed education is the first listed.
NCT00567294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00567294 about?
NCT00567294 is a clinical study titled "Evaluating Ways to Improve Medication Use Among People With Osteoporosis". Osteoporosis is a common bone disease in older adults in which the bones become weaker and prone to fracture. Medications are available to slow or even stop disease progression. However, very few adults who are prescribed osteoporosis medications actually follow through with filling their prescripti...
What is the current status of trial NCT00567294?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,087 participants. The study started on 2007-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00567294?
The interventions under investigation include: Mailed education (BEHAVIORAL), Telephone coaching program for patients (BEHAVIORAL), Medication adherence alert program for doctors (BEHAVIORAL).
Who is sponsoring clinical trial NCT00567294?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00567294's enrollment target sits among peer trials
2,087 99th of 2000 higher than 1,902 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373564 · 2,076 participants · Phase 4
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia